• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

PsyCap Recap Jan 2022: Entheo Digital

Microdose by Microdose
February 15, 2022
in Events
Reading Time: 2 mins read
A A
PsyCap Recap Jan 2022: Entheo Digital

Digital health will play a crucial role in the future of medicine, with digital therapeutics playing an especially important role in the burgeoning psychedelic medicine industry.

The future of psychedelics will be more than simply popping some FDA-approved pills, as these potent compounds call for a more holistic and experiential approach to therapy. And digital platforms can help.

Entheo Digital is working to position itself as a leading innovator in this space. CEO Robin Arnott and Sandeep Prakash, Entheo’s Chief Scientific Officer spoke at the recent Psychedelic Capital event with a “Technology of Advanced Psychedelic Therapy” panel.

Psychedelic Therapy with Immersive Virtual Experiences

“Entheo was founded to distribute digital therapeutics for psychedelic therapies, specifically for immersive, experiential digital experiences that can be used as tools for psychedelic therapists and patients” says Robin Arnott.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

SoundSelf is Entheos’ featured product. In development for many years it uses sound and visuals to give people access to psychedelic-like states. The VR experience accomplishes this with a unique vocal feedback system. Using singing, chanting, or toning, there is then dynamic music and visualizations that respond to everything the user does with their voice.

Continue on your trip...

Wonderland 2023 Review: PsychMD

Microdose Announces Dr. Sam Clark, CEO of Terran Biosciences, as Wonderland 2023 Keynote Presenter

The World on Drugs: Documentary Premiere at Wonderland

“It can facilitate unified states of consciousness.Transpersonal states of consciousness, without a chemical without a drug. And we found it to be really excellent for psychedelic therapy, preparation, and integration.”

Here’s a clip from their presentation:

“The technology guides people into a pattern of breathing and vocal toning that activates the vagus nerve and decreases autonomic arousal, or makes you feel much more calm and relaxed. SoundSelf is a tool that can amplify any therapeutic process by precisely directing awareness within deeply relaxed states of consciousness.You’re opened up to more information from the body and in the psyche. It’s as if the doors of perception into our emotional and feeling roles are temporarily open and you’re given an opportunity to be with yourself in a new way.”

SoundSelf has several potential uses. On the patient side, it can help better prepare patients for therapy, thus increasing chances of better outcomes and the likelihood of continued use of psychedelic therapy.

For more information visit Entheo’s website

Purchase Lasix

and see their video presentation below.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Entheo Digital
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
PharmaTher Receives U.S. Patent For Ketamine

PharmaTher Receives U.S. Patent For Ketamine

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.